Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP4-613B23.5 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | NDUFA1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | AURKA | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | LCN8 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TRIM22 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | PITPNM2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CCDC51 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | CELF2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
mRNA | COL24A1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | KCNMB4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |